Fig. 2.

A The overall survival (OS) of the MM patients for the entire cohort. Median OS (months) with the 95% CI is shown. B The overall survival (OS) of the MM patients under the Isa-PD regimen according to the white blood cell (WBC) counts: 3000/μl or more (black) or less than 3000/μl (red). The hazard ratio (HR) with the 95% CI is shown. The survival curves were adjusted by the significant factors in the multivariate analysis. C The OS of the MM patients under the Isa-PD regimen according to the lymphocyte/monocyte ratio (LMR): 4 or more (black) or less than 4 (red). The hazard ratio (HR) with the 95% CI is shown. The survival curves were adjusted by the significant factors in the multivariate analysis. The number of patients at risk in each group is shown in the lower panel of each figure